Literature DB >> 16153431

Carbon monoxide inhalation ameliorates cold ischemia/reperfusion injury after rat liver transplantation.

Takashi Kaizu1, Atsunori Nakao, Allan Tsung, Hideyoshi Toyokawa, Rohit Sahai, David A Geller, Noriko Murase.   

Abstract

BACKGROUND: Carbon monoxide (CO), a product of heme degradation by heme oxygenase, induces cytoprotection against ischemia/reperfusion (I/R) injury in a variety of organs such as the heart, lung, kidney, and small intestine. We examined whether CO would protect liver grafts against cold I/R injury associated with transplantation.
METHODS: Orthotopic liver transplantation (OLT) was performed in syngeneic Lewis rats with 18 hours preservation in cold University of Wisconsin solution. Recipients were exposed to air or CO (100 ppm) for 1 hour before and 24 hours after OLT. Recipients were sacrificed 0.5 to 48 hours post-transplant.
RESULTS: CO inhalation significantly decreased serum aspartate aminotransferase and alanine aminotransferase levels and suppressed hepatic necrosis formation and neutrophil accumulation at 6 to 48 hours after OLT, compared with air control. The expressions of tumor necrosis factor alpha, intercellular adhesion molecule 1, and inducible nitric oxide synthase messenger RNA in the liver graft were significantly inhibited in the CO-treated group at 1 hour after reperfusion. Hepatic nuclear factor-kappaB activation did not differ between the groups.
CONCLUSIONS: The results demonstrate that exogenous CO treatment suppresses early proinflammatory gene expression and neutrophil infiltration, and efficiently ameliorates hepatic I/R injury. The possible mechanism by which CO protects the liver against cold I/R does not seem to be associated with downregulation of the nuclear factor-kappaB-signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16153431     DOI: 10.1016/j.surg.2005.06.015

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  33 in total

Review 1.  Use of carbon monoxide in minimizing ischemia/reperfusion injury in transplantation.

Authors:  Kikumi S Ozaki; Shoko Kimura; Noriko Murase
Journal:  Transplant Rev (Orlando)       Date:  2011-10-13       Impact factor: 3.943

2.  Carbon monoxide liberated from CO-releasing molecule (CORM-2) attenuates ischemia/reperfusion (I/R)-induced inflammation in the small intestine.

Authors:  Kazuhiro Katada; Aurelia Bihari; Shinjiro Mizuguchi; Norimasa Yoshida; Toshikazu Yoshikawa; Douglas D Fraser; Richard F Potter; Gediminas Cepinskas
Journal:  Inflammation       Date:  2010-04       Impact factor: 4.092

3.  Arginase blockade protects against hepatic damage in warm ischemia-reperfusion.

Authors:  Geetha Jeyabalan; John R Klune; Atsunori Nakao; Nicole Martik; Guoyao Wu; Allan Tsung; David A Geller
Journal:  Nitric Oxide       Date:  2008-04-14       Impact factor: 4.427

4.  Inhalation of hydrogen gas reduces liver injury during major hepatotectomy in swine.

Authors:  Lei Xiang; Jing-Wang Tan; Li-Jie Huang; Lin Jia; Ya-Qian Liu; Yu-Qiong Zhao; Kai Wang; Jia-Hong Dong
Journal:  World J Gastroenterol       Date:  2012-10-07       Impact factor: 5.742

5.  Carbon monoxide-releasing molecule-2 (CORM-2) attenuates acute hepatic ischemia reperfusion injury in rats.

Authors:  Yunwei Wei; Ping Chen; Marco de Bruyn; Weihui Zhang; Edwin Bremer; Wijnand Helfrich
Journal:  BMC Gastroenterol       Date:  2010-05-05       Impact factor: 3.067

Review 6.  Carbon monoxide in exhaled breath testing and therapeutics.

Authors:  Stefan W Ryter; Augustine M K Choi
Journal:  J Breath Res       Date:  2013-02-27       Impact factor: 3.262

Review 7.  Carbon monoxide in lung cell physiology and disease.

Authors:  Stefan W Ryter; Kevin C Ma; Augustine M K Choi
Journal:  Am J Physiol Cell Physiol       Date:  2017-11-08       Impact factor: 4.249

Review 8.  Molecular mediators of liver ischemia and reperfusion injury: a brief review.

Authors:  Andrew J Vardanian; Ronald W Busuttil; Jerzy W Kupiec-Weglinski
Journal:  Mol Med       Date:  2008 May-Jun       Impact factor: 6.354

Review 9.  Heme oxygenase-1/carbon monoxide: from metabolism to molecular therapy.

Authors:  Stefan W Ryter; Augustine M K Choi
Journal:  Am J Respir Cell Mol Biol       Date:  2009-07-17       Impact factor: 6.914

10.  Carbon monoxide blocks lipopolysaccharide-induced gene expression by interfering with proximal TLR4 to NF-kappaB signal transduction in human monocytes.

Authors:  Maneesha Chhikara; Shuibang Wang; Steven J Kern; Gabriela A Ferreyra; Jennifer J Barb; Peter J Munson; Robert L Danner
Journal:  PLoS One       Date:  2009-12-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.